SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676098
Filing Date
2016-08-09
Accepted
2016-08-09 09:01:28
Documents
61
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d190233d10q.htm 10-Q 435250
2 LICENSE AND DEVELOPMENT AGREEMENT d190233dex101.htm EX-10.1 273332
3 CERTIFICATION d190233dex311.htm EX-31.1 6035
4 CERTIFICATION d190233dex312.htm EX-31.2 6140
5 CERTIFICATION d190233dex321.htm EX-32.1 2739
6 CERTIFICATION d190233dex322.htm EX-32.2 2855
  Complete submission text file 0001193125-16-676098.txt   3489722

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bdsi-20160630.xml EX-101.INS 465713
8 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20160630.xsd EX-101.SCH 53260
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20160630_cal.xml EX-101.CAL 54746
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20160630_def.xml EX-101.DEF 161939
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20160630_lab.xml EX-101.LAB 380960
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20160630_pre.xml EX-101.PRE 259884
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 161816324
SIC: 2834 Pharmaceutical Preparations